All In Biotech

Drug Trial Radar · NCT07169578

A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)

Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,101 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,101

Actual

Start

Sep 17, 2025

Primary completion

Feb 16, 2028

Study completion Feb 16, 2028

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Sep 12, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to AD).

Conditions

  • Alzheimers Disease

Interventions

  • TrontinemabDrug

    Participants will receive IV trontinemab.

  • PlaceboOther

    Participants will receive IV placebo.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 72 in Clinical Dementia Rating, Sum of Boxes (CDR-SB)Time frame: Baseline - Week 72

Locations

142 sites in 13 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Banner Sun Health Research Institute

    Sun City, Arizona

  • Irvine Center for Clinical Research

    Irvine, California

  • Inglewood Clinicals

    Los Angeles, California

  • UCSF - Memory and Aging Center

    San Francisco, California

  • Syrentis Clinical Research

    Santa Ana, California

  • K2 Medical Research - The Villages

    Lady Lake, Florida

  • K2 Medical Research, LLC

    Maitland, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Axiom Brain Health LLC

    Tampa, Florida

  • Charter Research - Lady Lake/The Villages

    The Villages, Florida

  • Alzheimer?s Research and Treatment Center

    Wellington, Florida

  • Conquest Research, LLC

    Winter Park, Florida

  • Alzheimer's Research and Treatment Center - Columbus

    Columbus, Georgia

  • Accel Research Sites-NeuroStudies

    Decatur, Georgia

  • Hawaii Pacific Neuroscience

    Honolulu, Hawaii

  • RE:Cognition (Chicago)

    Chicago, Illinois

  • Tandem Clinical Research, LLC

    Marrero, Louisiana

  • Brigham and Womens Hospital

    Boston, Massachusetts

  • Boston Center for Memory

    Newton, Massachusetts

  • Washington University School of Medicine

    St Louis, Missouri

  • The Cognitive and Research Center of New Jersey

    Ridgewood, New Jersey

  • Basil Clinical

    Laurelton, New York

  • Weill Cornell Medical College

    New York, New York

  • Adams Clinical Harlem

    New York, New York

  • Adams Clinical Bronx

    The Bronx, New York

  • Triad Clinical Trials

    Greensboro, North Carolina

  • Ohio State University

    Columbus, Ohio

  • Butler Hospital

    Providence, Rhode Island

  • Genesis Neuroscience Clinic

    Knoxville, Tennessee

  • K2 Medical Research - Nashville

    Nashville, Tennessee

  • Kerwin Research Center, LLC

    Dallas, Texas

  • South Texas Research Institute - Edinburg

    Edinburg, Texas

  • Re:Cognition Health - Houston

    Houston, Texas

  • National Clinical Research Inc.-Richmond

    Richmond, Virginia

  • Hospital Italiano

    CABA, Argentina

  • Hospital das Clinicas - UFMG

    Belo Horizonte, Minas Gerais, Brazil

  • Hospital Moinhos de Vento

    Porto Alegre, Rio Grande do Sul, Brazil

  • Centro de Pesquisas Clinicas - CPCLIN

    São Paulo, São Paulo, Brazil

  • Alpha Recherche Clinique

    Québec, Canada

Showing 40 of 142 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.